CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Recor Medical

The RADIANCE-HTN Clinical study is a randomized, controlled study to evaluate the Paradise Renal Denervation System intended to treat high blood pressure. The study will be in up to 40 hospitals in 5 countries (US, France, Germany, The Netherlands, UK...

TWG Market Research

TWG Market Research is a Barrington, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Validation Professionals

Validation Professionals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helaina

Helaina is a biotech company that uses precision fermentation to bring the immunity support of proteins found in breast milk to infant formula and functional foods for all ages.

ISK Biosciences Corporation

ISK Biosciences Corporation is a Painesville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.